Reviews Lifestyle The New Sober Boom Getting Hooked on Quitting Education Liberal Arts Cuts Are Dangerous Is College Necessary? Finance Dying Parents Costing Millennials Dear Gen Z Investing In Le Creuset Crypto Investing SEC vs Celebrity Crypto Promoters ‘Dark’ Personalities Drawn to BTC

Lifestyle The New Sober Boom Getting Hooked on Quitting

Getting Hooked on Quitting

Education Liberal Arts Cuts Are Dangerous Is College Necessary?

Liberal Arts Cuts Are Dangerous

Is College Necessary?

Finance Dying Parents Costing Millennials Dear Gen Z Investing In Le Creuset

Dying Parents Costing Millennials Dear

Gen Z Investing In Le Creuset

Crypto Investing SEC vs Celebrity Crypto Promoters ‘Dark’ Personalities Drawn to BTC

Investing SEC vs Celebrity Crypto Promoters ‘Dark’ Personalities Drawn to BTC

SEC vs Celebrity Crypto Promoters

‘Dark’ Personalities Drawn to BTC

Reviews Lifestyle The New Sober Boom Getting Hooked on Quitting Education Liberal Arts Cuts Are Dangerous Is College Necessary? Finance Dying Parents Costing Millennials Dear Gen Z Investing In Le Creuset Crypto Investing SEC vs Celebrity Crypto Promoters ‘Dark’ Personalities Drawn to BTC

Lifestyle The New Sober Boom Getting Hooked on Quitting

Getting Hooked on Quitting

Education Liberal Arts Cuts Are Dangerous Is College Necessary?

Liberal Arts Cuts Are Dangerous

Is College Necessary?

Finance Dying Parents Costing Millennials Dear Gen Z Investing In Le Creuset

Dying Parents Costing Millennials Dear

Gen Z Investing In Le Creuset

Crypto Investing SEC vs Celebrity Crypto Promoters ‘Dark’ Personalities Drawn to BTC

Investing SEC vs Celebrity Crypto Promoters ‘Dark’ Personalities Drawn to BTC

SEC vs Celebrity Crypto Promoters

‘Dark’ Personalities Drawn to BTC

After years of waiting, many opioid victims will be shut out of Purdue settlement

Nearly 140,000 people filed claims against the company for the harm they said its drugs caused

Published April 24, 2026 6:00AM (EDT)

This article originally appeared on ProPublica.

Mary Jannotta sliced meat and cheese behind deli counters at Acme and Pathmark supermarkets in the Philadelphia suburbs for decades, developing aches that came with working on her feet. A botched back surgery in 2008 made the pain worse. Her doctor repeatedly prescribed OxyContin, Purdue Pharma’s marquee painkiller — the high-dose opioid the company later admitted it criminally marketed and distributed.

Jannotta said she soon became dependent on opioids. Cut off by her doctors, she found her way to Kensington, home of Philadelphia’s dangerous open-air drug market, to score pills. She eventually lost her car, her home — and her grandson. Tyler Cordeiro first pilfered Jannotta’s prescription pills as a teenager. He was 24 when he died of an overdose.

When Purdue filed for bankruptcy in 2019, Jannotta, along with nearly 140,000 other people, filed claims against the company for the harm they said its drugs caused. Though the money could not bring back what they lost, a financial settlement represented an opportunity to get justice from the company and its multibillionaire owners, the Sackler family.

Then they waited. The Supreme Court in 2024 rejected the first bankruptcy settlement because it shielded the Sacklers from future lawsuits. Finally, last November, a federal judge approved a new plan that would allow the payouts to start.

But this $7.4 billion bankruptcy plan — including $870 million that has been set aside for individual victims — will shut out tens of thousands of those who originally applied for a settlement, ProPublica and The Philadelphia Inquirer found. Fewer than half of those who filed claims against Purdue will get any kind of help under the new plan, despite the company touting it as “the only opioid settlement to date that meaningfully compensates individual victims.”

Court records show the new plan slashed payments for victims, imposed tougher eligibility requirements and eliminated compensation for teenagers who bought Purdue drugs on the street. Estimated settlement amounts for people whose family members fatally overdosed dropped to as little as $8,000; the previous payout for an OxyContin death had been $48,000.

Most significantly, the new plan removed a key provision that allowed victims to submit a sworn affidavit, in lieu of a prescription or other medical or legal records, to prove they purchased Purdue opioids.

Similar sworn statements have been........

© Salon